HomeTSHA • NASDAQ
add
Taysha Gene Therapies Inc
Previous close
$4.86
Day range
$4.72 - $4.92
Year range
$1.05 - $5.51
Market cap
1.30B USD
Avg Volume
3.99M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 34.02M | 48.91% |
Net income | -32.73M | -28.24% |
Net profit margin | — | — |
Earnings per share | -0.09 | -22.87% |
EBITDA | -33.74M | -62.47% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 297.34M | 88.56% |
Total assets | 316.55M | 75.65% |
Total liabilities | 97.56M | 6.72% |
Total equity | 218.99M | — |
Shares outstanding | 273.92M | — |
Price to book | 6.08 | — |
Return on assets | -26.18% | — |
Return on capital | -28.52% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -32.73M | -28.24% |
Cash from operations | -24.17M | -11.80% |
Cash from investing | -48.00K | -37.14% |
Cash from financing | 8.80M | 33.39% |
Net change in cash | -15.42M | -2.40% |
Free cash flow | -13.42M | -6.45% |
About
Founded
2019
Headquarters
Website
Employees
73
